The first 1 billion Chinese ointments were born TOP10 ranking change.

Pharmaceutical Network August 4th, paste is a modern transdermal drug preparation, mainly used in the field of anti-inflammatory analgesic.
Minet data show that in recent years, China's public medical institutions in the terminal of the market for ointment sainp.
TOP10 product sales are more than 100 million yuan, orthopaedic painkillers accounted for half of the mountain, Yunnan white ointment sales exceeded 1 billion scale, and pain cream followed closely behind;
it is worth mentioning that 8 of TOP10 products are exclusive, involving Yunnan white medicine, Qizheng Tibetan medicine, Antelope Pharmaceuticals, Jiangsu Kangyuan Sunshine Pharmaceuticals and other enterprises.
TOP10 product ranking change! Qizheng, Kangyuan ... 8 exclusive products "bascreen" in recent years, China's public medical institutions terminal sedative paste sales channel pattern Minet net data show that in recent years in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminals in the market for the steady growth of the market for ointments.
sales channels, urban public hospitals are on a downward trend, with market share declining from more than 50% to 43.89% in 2019, while county-level public hospitals, urban community centers and township hospitals are growing rapidly.
2019 China's urban public medical institutions in the end of the ointment products TOP10 Note: market share retention integer from TOP10 products, sales are more than 100 million yuan, high market concentration, the total accounted for more than 70% of the Chinese medicine paste market, orthopaedic painkillers accounted for half of the wall.
, Yunnan white ointment sales exceeded 1 billion scale, and pain cream followed closely behind;
it is worth mentioning that 8 of TOP10 products are exclusive, involving Yunnan white medicine, Qizheng Tibetan medicine, Antelope Pharmaceuticals, Jiangsu Kangyuan Sunshine Pharmaceuticals and other enterprises.
the birth of the first 1 billion Chinese-made ointment paste, pain-relieving paste followed in recent years China's public medical institutions terminal Yunnan white ointment sales situation Yunnan white ointment is the exclusive product of Yunnan white ointment, is one of the clinically commonly used drugs, there is live hemorrhoids, swelling, anti-humidity effect, used for beating injury, hematomable, rheumatism pain.
Minet data show that in recent years, China's public medical institutions terminal Yunnan white ointment sales have grown steadily, in 2019 to break through the 1 billion mark.
data show that Yunnan White Pharmaceuticals through the three shareholders of Bai Pharma Holdings Yunnan State-owned Assets Supervision and Administration Commission, Xinhua Du and Jiangsu Fish Leap issued shares to the white medicine holdings to implement the absorption of the merger, in June 2019 to complete the delivery.
company continued to deep-cultivation pharmaceuticals, health products, Chinese medicine resources and pharmaceutical business and other four business sectors, the performance of a steady increase.
in recent years, China's public medical institutions terminal pain cream sales is the exclusive product of Qizheng Tibetan medicine, mainly used for acute and chronic twisting bruises, falls and bruises, bone hyperpluse, rheumatism and rheumatoid pain.
-meter-net data show that in 2019 China's public medical institutions terminal pain cream sales are close to the 1 billion mark.
Qizheng Medicine in the annual report pointed out that the company continued to promote the "big analgesics category, build pain integrated solution first brand" brand objectives, focusing on the skeletal muscle pain field, products to pain cream-based, combined with green peng ointment, white pulse ointment and other products, the skeletal muscle pain field market segmentation, for doctors and patients to provide clinical value and specialty therapy classics.
combined with modern medicine on skeletal muscle pain disease "prevention, treatment, rehabilitation" standardized management trilogy concept, deep integration of chain customer management needs and consumer health management needs, do real channel sinking to improve product accessibility, improve multi-product coverage, and further from a single product-led to a rich pain category management transition.
more than 10%! 3 product growth rate bright eyes in recent years China's public medical institutions terminal through the pain cream sales situation is the exclusive products of Antelope Pharmaceuticals, can live blood flow, cold dehumidification, swelling and pain relief.
is used for lumbar and knee osteoarthritis stasis, cold and wet resistance evidence.
-meter net data show that in 2019, China's public medical institutions terminal pain cream sales exceeded 500 million scale, up 15.60% year-on-year.
data show that the main product pipeline of Antelope Pharmaceuticals focuses on orthopaedic diseases, cardiovascular diseases and other fields, the current main production and sale of drugs have a general erythromyl, bone musk painkillers and other products.
the development of cardiovascular, orthopaedic and other exclusive varieties with clinical efficacy basis for secondary development work, which, completed the study of the enveloping pain paste dermal penetration, paste paste division to improve the anti-inflammatory analgesic anointing production process research and recovery work.
Antelope Pharmaceuticals said that the secondary development of Traditional Chinese Medicine to promote the upgrading of the company's products, enhance the market competitiveness of traditional Chinese medicine to provide modern scientific and technological support.
in recent years, China's public medical institutions terminal musk chasing wind pain cream sales situation musk chasing wind pain cream is the exclusive product of Chongqing Hill an Pharmaceutical, with the role of dehumidification, cold pain relief, used for cold and wet paralysis caused by joint, muscle pain, sprain pain.
-meter net data show that in the past two years, the sales of musk wind-chasing pain cream in China's public medical institutions have increased by more than 10%.
in recent years, China's public medical institutions terminal Shennon analgesic paste sales situation Shennon analgesic cream is live blood scattered, anti-swelling pain, used for falling injury, rheumatic joint pain, back soreness.
-meter net data show that in recent years, Shennon analgesic sorority in China's public medical institutions terminal sales growth, from more than 40 million yuan in 2015 to nearly 150 million yuan in 2019, among the product TOP10.
at present, the product manufacturers have Zhanjiang Jimin Pharmaceuticals, Huangshi Yan dance pharmaceutical and Antelope Pharmaceuticals, of which Zhanjiang Jimin Pharmaceuticals has the largest market share, accounting for nearly 60%.
in recent years, the state attaches great importance to the development of the Chinese medicine industry, pharmaceutical enterprises continue to increase investment in research and development, Chinese medicine paste products are constantly updated, with its long-lasting effects, small toxic side effects, easy to use and other advantages favored by patients, the market has gradually become a climate.
the future, industry concentration may be further enhanced.
source: Minnet database, company announcementifs if there are omissions, welcome to correct!